Sterling Stands to Benefit From Higher Rates -2-
1149 GMT - Sales of GSK's respiratory syncytial virus vaccine Arexvy are expected to peak at $4 billion and could surpass consensus, Jefferies analysts say in a note. This drug, together with... | May 30, 2023
Source: marketscreener.com